BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30746961)

  • 21. Characterization of Hydrophilic Gold(I) N-Heterocyclic Carbene (NHC) Complexes as Potent TrxR Inhibitors Using Biochemical and Mass Spectrometric Approaches.
    Karaca Ö; Scalcon V; Meier-Menches SM; Bonsignore R; Brouwer JMJL; Tonolo F; Folda A; Rigobello MP; Kühn FE; Casini A
    Inorg Chem; 2017 Nov; 56(22):14237-14250. PubMed ID: 29095609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of New Monocarbonyl Ligustrazine-Curcumin Hybrids for Intervention of Drug-Sensitive and Drug-Resistant Lung Cancer.
    Ai Y; Zhu B; Ren C; Kang F; Li J; Huang Z; Lai Y; Peng S; Ding K; Tian J; Zhang Y
    J Med Chem; 2016 Mar; 59(5):1747-60. PubMed ID: 26891099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and anticancer activity of Michael-type thiol adducts of α-santonin analogue with exocyclic methylene.
    Khazir J; Riley DL; Chashoo G; Mir BA; Liles D; Islam MA; Singh SK; Vishwakarma RA; Pilcher LA
    Eur J Med Chem; 2015 Aug; 101():769-79. PubMed ID: 26222449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osmocenyl-tamoxifen derivatives target the thioredoxin system leading to a redox imbalance in Jurkat cells.
    Scalcon V; Top S; Lee HZ; Citta A; Folda A; Bindoli A; Leong WK; Salmain M; Vessières A; Jaouen G; Rigobello MP
    J Inorg Biochem; 2016 Jul; 160():296-304. PubMed ID: 27130146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-thiol farnesyltransferase inhibitors: FTase-inhibition and cellular activity of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors.
    Mitsch A; Bergemann S; Gust R; Sattler I; Schlitzer M
    Arch Pharm (Weinheim); 2003 Jul; 336(4-5):242-50. PubMed ID: 12916059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dithiaarsanes induce oxidative stress-mediated apoptosis in HL-60 cells by selectively targeting thioredoxin reductase.
    Liu Y; Duan D; Yao J; Zhang B; Peng S; Ma H; Song Y; Fang J
    J Med Chem; 2014 Jun; 57(12):5203-11. PubMed ID: 24867309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
    Thapa P; Karki R; Choi H; Choi JH; Yun M; Jeong BS; Jung MJ; Nam JM; Na Y; Cho WJ; Kwon Y; Lee ES
    Bioorg Med Chem; 2010 Mar; 18(6):2245-2254. PubMed ID: 20188578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors.
    Rackham O; Shearwood AM; Thyer R; McNamara E; Davies SM; Callus BA; Miranda-Vizuete A; Berners-Price SJ; Cheng Q; Arnér ES; Filipovska A
    Free Radic Biol Med; 2011 Mar; 50(6):689-99. PubMed ID: 21172426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism-based design, synthesis and biological studies of N⁵-substituted tetrahydrofolate analogs as inhibitors of cobalamin-dependent methionine synthase and potential anticancer agents.
    Zhang Z; Tian C; Zhou S; Wang W; Guo Y; Xia J; Liu Z; Wang B; Wang X; Golding BT; Griff RJ; Du Y; Liu J
    Eur J Med Chem; 2012 Dec; 58():228-36. PubMed ID: 23124219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and pharmacological evaluation of novel substituted quinoline-2-carboxamide derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors and anticancer agents.
    Vyas VK; Variya B; Ghate MD
    Eur J Med Chem; 2014 Jul; 82():385-93. PubMed ID: 24929289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory nitrosylation of mammalian thioredoxin reductase 1: Molecular characterization and evidence for its functional role in cellular nitroso-redox imbalance.
    Engelman R; Ziv T; Arnér ESJ; Benhar M
    Free Radic Biol Med; 2016 Aug; 97():375-385. PubMed ID: 27377780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selenadiazole derivatives as potent thioredoxin reductase inhibitors that enhance the radiosensitivity of cancer cells.
    Liang YW; Zheng J; Li X; Zheng W; Chen T
    Eur J Med Chem; 2014 Sep; 84():335-42. PubMed ID: 25036792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors.
    Zhang YB; Wang XL; Liu W; Yang YS; Tang JF; Zhu HL
    Bioorg Med Chem; 2012 Nov; 20(21):6356-65. PubMed ID: 23018096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of thioredoxin reductase by mansonone F analogues: Implications for anticancer activity.
    Liu Z; Huang SL; Li MM; Huang ZS; Lee KS; Gu LQ
    Chem Biol Interact; 2009 Jan; 177(1):48-57. PubMed ID: 18822278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of thioredoxin reductase 1 by porphyrins and other small molecules identified by a high-throughput screening assay.
    Prast-Nielsen S; Dexheimer TS; Schultz L; Stafford WC; Cheng Q; Xu J; Jadhav A; Arnér ES; Simeonov A
    Free Radic Biol Med; 2011 May; 50(9):1114-23. PubMed ID: 21262347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1).
    Omata Y; Folan M; Shaw M; Messer RL; Lockwood PE; Hobbs D; Bouillaguet S; Sano H; Lewis JB; Wataha JC
    Toxicol In Vitro; 2006 Sep; 20(6):882-90. PubMed ID: 16510263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and biological evaluation of N-phenyl-(2,4-dihydroxypyrimidine-5-sulfonamido)benzoyl hydrazide derivatives as thymidylate synthase (TS) inhibitors and as potential antitumor drugs.
    Li XY; Liang JW; Mohamed O K; Zhang TJ; Lu GQ; Meng FH
    Eur J Med Chem; 2018 Jun; 154():267-279. PubMed ID: 29807332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simvastatin inhibits the core promoter of the TXNRD1 gene and lowers cellular TrxR activity in HepG2 cells.
    Ekström L; Johansson M; Monostory K; Rundlöf AK; Arnér ES; Björkhem-Bergman L
    Biochem Biophys Res Commun; 2013 Jan; 430(1):90-4. PubMed ID: 23154180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, biological evaluation and molecular modeling studies of some novel thiazolidinediones with triazole ring.
    Chinthala Y; Kumar Domatti A; Sarfaraz A; Singh SP; Kumar Arigari N; Gupta N; Satya SK; Kotesh Kumar J; Khan F; Tiwari AK; Paramjit G
    Eur J Med Chem; 2013; 70():308-14. PubMed ID: 24177357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and biological evaluation of novel spiro-pentacylamides as acetyl-CoA carboxylase inhibitors.
    Wei Q; Mei L; Yang Y; Ma H; Chen H; Zhang H; Zhou J
    Bioorg Med Chem; 2018 Aug; 26(14):3866-3874. PubMed ID: 30049586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.